biotech

FDA Gives Tentative Approval to New Generic AIDS Drug

Filed in archive Drugs, Vaccines and Therapeutics on May 22, 2006

FDA Gives Tentative Approval to New Generic AIDS Drug
As part of President Bush's global AIDS relief plan, the US FDA has issued a tentative approval to generic abacavir sulfate tablets, a generic version of GlaxoSmithKline's Ziagen, an anti-HIV medication. Abacavir belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NRTIs), and is used in combination with other antiretroviral agents to inhibit HIV replication.

The drug, manufactured by India-based Aurobindo Pharma Ltd., will now be available for consideration for purchase under the President's Emergency Plan for AIDS Relief.

[Photo: Ziagen tablet, from CORE Center]

Permalink: FDA Gives Tentative Approval to New Generic AIDS Drug

Tags: HIV  AIDS  biotech  aids  drug  aids+drug  approval+generic  tentative+approval 

Vote for FDA Gives Tentative Approval to New Generic AIDS Drug:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 2 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells